JPH0196109A - Skin-beautifying cosmetic - Google Patents
Skin-beautifying cosmeticInfo
- Publication number
- JPH0196109A JPH0196109A JP25187587A JP25187587A JPH0196109A JP H0196109 A JPH0196109 A JP H0196109A JP 25187587 A JP25187587 A JP 25187587A JP 25187587 A JP25187587 A JP 25187587A JP H0196109 A JPH0196109 A JP H0196109A
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- phytosterol
- skin
- kojic acid
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 36
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims abstract description 28
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229960004705 kojic acid Drugs 0.000 claims abstract description 26
- -1 fatty acid ester Chemical class 0.000 claims abstract description 22
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 5
- 239000000194 fatty acid Substances 0.000 claims abstract description 5
- 229930195729 fatty acid Natural products 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims abstract description 3
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims abstract description 3
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 claims abstract description 3
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 claims abstract description 3
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 claims abstract description 3
- 235000000431 campesterol Nutrition 0.000 claims abstract description 3
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 3
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims abstract description 3
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 claims abstract description 3
- 229940032091 stigmasterol Drugs 0.000 claims abstract description 3
- 235000016831 stigmasterol Nutrition 0.000 claims abstract description 3
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229940076810 beta sitosterol Drugs 0.000 claims abstract 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims abstract 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims abstract 2
- 229950005143 sitosterol Drugs 0.000 claims abstract 2
- 230000002087 whitening effect Effects 0.000 claims description 29
- 239000000126 substance Substances 0.000 claims description 9
- 229940068065 phytosterols Drugs 0.000 claims description 7
- 229930182470 glycoside Natural products 0.000 claims description 2
- 150000002338 glycosides Chemical class 0.000 claims description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000006210 lotion Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 12
- 239000006071 cream Substances 0.000 abstract description 6
- 125000002947 alkylene group Polymers 0.000 abstract description 3
- 125000003545 alkoxy group Chemical group 0.000 abstract description 2
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 229930182478 glucoside Natural products 0.000 abstract description 2
- 150000008131 glucosides Chemical class 0.000 abstract description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 210000002752 melanocyte Anatomy 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 241000589220 Acetobacter Species 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- CSUUDNFYSFENAE-UHFFFAOYSA-N (2-methoxyphenyl)-phenylmethanone Chemical compound COC1=CC=CC=C1C(=O)C1=CC=CC=C1 CSUUDNFYSFENAE-UHFFFAOYSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HMFKFHLTUCJZJO-UHFFFAOYSA-N 2-{2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCC(OCCO)C1OCC(OCCO)C1OCCO HMFKFHLTUCJZJO-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229940071120 dehydroacetate Drugs 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- BAQKJENAVQLANS-UHFFFAOYSA-N fenbutrazate Chemical compound C=1C=CC=CC=1C(CC)C(=O)OCCN(C1C)CCOC1C1=CC=CC=C1 BAQKJENAVQLANS-UHFFFAOYSA-N 0.000 description 1
- 229960002533 fenbutrazate Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- WYVGZXIHGGQSQN-UHFFFAOYSA-N hexadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCCCCC(O)=O WYVGZXIHGGQSQN-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- DLINORNFHVEIFE-UHFFFAOYSA-N hydrogen peroxide;zinc Chemical compound [Zn].OO DLINORNFHVEIFE-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229960004995 magnesium peroxide Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- TVMQDNRQQWQICK-UHFFFAOYSA-M sodium;6-(hydroxymethyl)-4-oxopyran-3-olate Chemical compound [Na+].OCC1=CC(=O)C([O-])=CO1 TVMQDNRQQWQICK-UHFFFAOYSA-M 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229940105296 zinc peroxide Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は美白効果に優れた化粧料に関するものである。[Detailed description of the invention] [Industrial application field] The present invention relates to cosmetics with excellent whitening effects.
更に詳しくは、コウジ酸及び/又はその誘導体とフィト
ステロール及び/又はその誘導体を化粧料基剤に配合し
、美白効果を改善せしめた美白化粧料に関するものであ
る。More specifically, the present invention relates to a whitening cosmetic composition in which kojic acid and/or its derivatives and phytosterols and/or its derivatives are blended into a cosmetic base to improve the whitening effect.
皮I#美白効果を有する化粧料は消費者、特に20代後
半の女性には関心が極めて高く、特に、シミの改善につ
いては、安全で且つ実効果のあるものが従来から要望さ
れている。そのため、多くの研究者らによって、シミ発
生に関与すると考えられるチロシナーゼ酵素の活性抑制
及び活性メラノサイトの消失等を指標に、美白成分の探
索及び種々の美白化粧料が研究開発又は提供されている
。Consumers, especially women in their late twenties, are very interested in cosmetics that have a skin whitening effect, and there has been a long-standing desire for products that are both safe and effective, especially for the improvement of age spots. Therefore, many researchers are searching for whitening ingredients and researching, developing, or providing various whitening cosmetics based on the inhibition of the activity of tyrosinase enzyme and the disappearance of active melanocytes, which are thought to be involved in the generation of age spots.
美白化粧料を得るに、以前は過酸化水素、過酸化亜鉛、
過酸化マグネシウム等の過酸化物、アスコルビン酸、グ
ルタチオン、コロイド硫黄や各種天然物が美白成分とし
て配合されてきた。しかし。In the past, hydrogen peroxide, zinc peroxide,
Peroxides such as magnesium peroxide, ascorbic acid, glutathione, colloidal sulfur, and various natural products have been blended as whitening ingredients. but.
過酸化物やアスコルビン酸は安定性、保存性等に問題が
あり、またその効果も充分なものとは言い難い。一方、
グルタチオンやコロイド硫黄は異臭を有するため化粧料
への配合には難点があった。Peroxides and ascorbic acid have problems with stability, storage stability, etc., and their effects cannot be said to be sufficient. on the other hand,
Glutathione and colloidal sulfur have a strange odor, which makes it difficult to incorporate them into cosmetics.
更に、米国などではハイドロキノンを皮膚脱色剤として
使用しているが、このものは美白効果はあるものの安全
性(刺激性、アレルギー性)の面から化粧料に配合する
ことには問題がある。Furthermore, in the United States and other countries, hydroquinone is used as a skin bleaching agent, but although it has a whitening effect, it is problematic to incorporate it into cosmetics due to safety (irritancy, allergy).
従って、最近では上記の如き問題のない皮膚美白効果を
有する種々の美白成分又は化粧料が鋭意開発されている
0例えば、アスペルギルス属、ペニシリウム属、アセト
バクター属等から生産されるコウジ酸及びコウジ酸誘導
体を用いた美白化粧料が提案されている(特公昭56−
18569号、特開昭53−3538号、特公昭61−
60801号、特公昭58−22151号、特公昭60
−9722号)、また、クエルセチン及び/又はその誘
導体を有効成分とする化粧料(特開昭55−92305
号、特開昭58−131911号)、カテキン等を有効
成分とする化粧料(特開昭52−44375号)等も開
発されているが、実際の使用に際しては、それら美白成
分の安定性が未だ不十分であったり、また細胞レベルで
は効果が認められるものの、動物、ヒトではその効果が
充分に発揮できない等の種々の問題が残されているのが
現状である。Therefore, recently, various whitening ingredients or cosmetics that have skin whitening effects without the problems mentioned above have been intensively developed.For example, kojic acid and kojic acid produced from Aspergillus, Penicillium, Acetobacter, etc. Whitening cosmetics using derivatives have been proposed (Special Publication No. 1983-
No. 18569, JP-A No. 53-3538, JP-A No. 61-
No. 60801, Special Publication No. 58-22151, Special Publication No. 1983
-9722), and cosmetics containing quercetin and/or its derivatives as an active ingredient (JP-A-55-92305).
Cosmetics containing catechins as active ingredients (Japanese Patent Application Laid-Open No. 52-44375) have also been developed, but the stability of these whitening ingredients is difficult to find in actual use. At present, various problems remain, such as that it is still insufficient, and that although it is effective at the cellular level, it is not fully effective in animals and humans.
本発明は前記の問題を解決し、美白効果に優れた化粧料
を提供することを目的とする。The present invention aims to solve the above-mentioned problems and provide a cosmetic with excellent whitening effects.
更に詳しくは、本発明は、美白成分として知られている
コウジ酸及び/又はその誘導体の美白効果をより改善さ
せる併用物質を配合した化粧料を提供することを目的と
する。More specifically, the present invention aims to provide a cosmetic containing a concomitant substance that further improves the whitening effect of kojic acid and/or its derivatives, which are known as whitening ingredients.
本発明者らは、シミの形態及び生理学的性状の検討で得
た知見、即ち、シミ部位は正常部位に比べ水分が低下し
、皮膚硬化していることに着目して、その皮膚状態の改
善をもたらし得る細胞間脂質やその類似構造物について
、コウジ酸及び/又はその誘導体との併用効果を検討し
たところ、コウジ酸及び/又はその誘導体に植物性ステ
ロイドであるフィトステロール及び/又はその誘導体を
併用することにより、コウジ酸及び/又はその誘導体の
美白効果をより改善できることを見いだした。本発明は
かかる知見に基づいて完成されたものである。The present inventors have focused on the knowledge obtained from the study of the morphology and physiological properties of age spots, namely that moisture content in the age spot area is lower than in normal areas and the skin is hardened, and we aim to improve the skin condition of the area. We investigated the effects of combining kojic acid and/or its derivatives with intercellular lipids and similar structures that can bring about the It has been found that the whitening effect of kojic acid and/or its derivatives can be further improved by doing so. The present invention was completed based on this knowledge.
即ち、本発明は、コウジ酸及び/又はその誘導体と下記
一般式(りで表わされるフィトステロール及び/又はそ
の誘導体を含有することを特徴とする美白化粧料を提供
するものである。That is, the present invention provides a whitening cosmetic composition characterized by containing kojic acid and/or a derivative thereof and a phytosterol represented by the following general formula (RI) and/or a derivative thereof.
○R1
前記式中R0は、水素原子、炭素数3〜22のアルキル
基、炭素数3−22のアルコキシ基、ポリオキシ化アル
キレン(炭素数2〜3)残基又は糖残基を表わす。R2
は、デシル基(C10H21−)、デセニル基(C1゜
Hxs−)又はノニル基(C,U、S−)を表わす。こ
の場合、ポリオキシ化アルキレン残基としては、例えば
式−(CJ*0)rr−Hl−(C3R70+r7Hで
示されるものが挙げられる。また糖残基としては、式−
C,Hllo、で示されるものが挙げられる。○R1 In the above formula, R0 represents a hydrogen atom, an alkyl group having 3 to 22 carbon atoms, an alkoxy group having 3 to 22 carbon atoms, a polyoxylated alkylene (having 2 to 3 carbon atoms) residue, or a sugar residue. R2
represents a decyl group (C10H21-), a decenyl group (C1°Hxs-) or a nonyl group (C, U, S-). In this case, examples of polyoxylated alkylene residues include those represented by the formula -(CJ*0)rr-Hl-(C3R70+r7H).As the sugar residues, examples of the formula -
Examples include those shown by C, Hllo.
本発明に使用されるコウジ酸は、化学名が5−ヒドロキ
シ−2−ヒドロキシメチル−4−ピロンであり、アスペ
ルギルス属、ペニシリウム属、アセトバクター属などの
微生物から生産される発酵抽出液や再結晶等による精製
品、あるいは合成的手法などにより得られた合成品が使
用できる。コウジ酸及びその塩は市販されており容易に
入手できる。The kojic acid used in the present invention has a chemical name of 5-hydroxy-2-hydroxymethyl-4-pyrone, and is produced from fermentation extracts and recrystallizations produced from microorganisms such as Aspergillus, Penicillium, and Acetobacter. or synthetic products obtained by synthetic methods can be used. Kojic acid and its salts are commercially available and can be easily obtained.
本発明におけるコウジ酸の誘導体は、コウジ酸の5−及
び/又は2−ヒドロキシ基の反応誘導体が含まれる。こ
のような誘導体としては、炭素数3−22の脂肪酸エス
テル、炭素数3−22の脂肪族エーテル、ポリオキシア
ルキレン(炭素数2−3)誘導体等を好ましいものとし
て挙げることができる。The derivatives of kojic acid in the present invention include reaction derivatives of 5- and/or 2-hydroxy groups of kojic acid. Preferred examples of such derivatives include fatty acid esters having 3 to 22 carbon atoms, aliphatic ethers having 3 to 22 carbon atoms, and polyoxyalkylene (2 to 3 carbon atoms) derivatives.
また、本発明に使用される前述の一般式(1)で表わさ
れるフィトステロールは植物界に広く分布するステロイ
ドアルコールに属し2植物油脂中では遊離状で存在する
他、エステルやグルコシドとして存在しており、大豆、
シアーバター、ニンジン等から分離、精製されたものが
使用できる。また、ライl−ステロールは単一の化合物
ではなく、おちにβ−シI−ステロール、スチグマステ
ロール、カンペステロールからなる混合物で、大豆フィ
トステロールの場合、その比率はおよそ2:1:1であ
る。In addition, the phytosterols represented by the above-mentioned general formula (1) used in the present invention belong to steroid alcohols widely distributed in the plant kingdom.2 In addition to existing in free form in vegetable oils, they also exist as esters and glucosides. ,soy,
Separated and purified products from shea butter, carrots, etc. can be used. In addition, Ly-l-sterol is not a single compound, but a mixture consisting of β-l-sterol, stigmasterol, and campesterol, and in the case of soybean phytosterol, the ratio is approximately 2:1:1. .
更に、フィトステロール及びその脂肪酸エステル、脂肪
族エーテル、ポリオキシアルキレン誘導体及び配糖体か
らなるフィトステロール誘導体は。Furthermore, phytosterol derivatives consisting of phytosterols and their fatty acid esters, aliphatic ethers, polyoxyalkylene derivatives and glycosides.
それ自体で乳化作用、乳化安定化作用および可溶化能を
有し、それらの誘導体が安価に市販されており、製品の
剤型に応じて使い分けることができる。市販品としては
、Generol 122シリーズ(ヘンケル白水社製
)及びN1kkol BPSシリーズ(日光ケミカルズ
社製)等が挙げられる。They themselves have emulsifying, emulsion stabilizing, and solubilizing abilities, and their derivatives are commercially available at low cost and can be used depending on the dosage form of the product. Commercially available products include the Generalol 122 series (manufactured by Henkel Hakusuisha) and the N1kkol BPS series (manufactured by Nikko Chemicals).
本発明においては、前述のコウジ酸及び/又はその誘導
体(以下、コウジ酸成分とも言う)と、フィトステロー
ル及び/又はその誘導体(以下、フィトステロール成分
とも言う)の両者を含有せしめることが必須であり、ど
ちらか一方のみを含有した化粧料では本発明の目的であ
る美白効果の改善は達成できない。本発明による美白効
果の改善は、フィトステロールの皮膚抗硬化又は整肌作
用により皮膚状態が改善され、美白剤であるコウジ酸の
角質層への移行をスムーズにして経皮吸収性を高めたこ
とと、フィトステロールの紫外線防御作用によってコウ
ジ酸の劣化を防止し、皮膚上に安定保持させたことによ
る相剰効果によるものと考えられる。In the present invention, it is essential to contain both the above-mentioned kojic acid and/or its derivative (hereinafter also referred to as kojic acid component) and phytosterol and/or its derivative (hereinafter also referred to as phytosterol component), Cosmetics containing only one of them cannot achieve the improvement in whitening effect, which is the objective of the present invention. The improvement in the whitening effect of the present invention is due to the fact that the skin condition is improved due to the skin anti-hardening or skin conditioning effect of phytosterols, and the transdermal absorption of kojic acid, which is a whitening agent, is increased by smoothing the transition to the stratum corneum. This is thought to be due to the mutual effect of preventing the deterioration of kojic acid due to the ultraviolet protection effect of phytosterols and stably retaining it on the skin.
本発明の美白化粧料には1例えば、クリーム。The whitening cosmetic of the present invention includes, for example, cream.
乳液、化粧水、パック剤、パウダー、リップクリーム、
口紅、アンダーメークアップ、ファンデーション、サン
ケア等多くのものが包含される。Emulsion, lotion, pack agent, powder, lip balm,
This includes lipstick, under-makeup, foundation, sun care, and many more.
前記コウジ酸及び/又はその誘導体と、フィトステロー
ル及び/又はその誘導体の化粧料への配合量は、剤型に
応じて任意に選択されるが、通常は、絃化粧料中にコウ
ジ酸成分が0.01〜10重量X。The amounts of the kojic acid and/or its derivatives and phytosterols and/or its derivatives to be added to the cosmetics are arbitrarily selected depending on the dosage form, but usually the kojic acid component is 0% in the cosmetics. .01-10 weight X.
フィトステロール成分が0.01〜25重量%になるよ
うに配合することが好ましい。配合量が0.01重量2
未満では本発明の好ましい効果が得られない。上限につ
いては特に制限はないが多量に配合した場合、製品の安
定性及びベトッキ等の使用感が劣るため、化粧料として
は好ましくなく、その配合量の上限は、コウジ酸成分の
場合10重量ダ及びフィトステロール成分の場合25重
量%にするのが好ましい。また、各成分の配合の方法は
、従来の生理活性成分等を配合する方法に準じて行なう
ことができる。It is preferable to mix the phytosterol component in an amount of 0.01 to 25% by weight. The blending amount is 0.01 weight 2
If the amount is less than that, the preferable effects of the present invention cannot be obtained. There is no particular upper limit on the upper limit, but if a large amount is blended, the stability of the product and the feeling of use such as stickiness will be poor, so it is not desirable for cosmetics. In the case of the phytosterol component, it is preferably 25% by weight. Moreover, the method of blending each component can be carried out in accordance with the conventional method of blending physiologically active ingredients and the like.
本発明の化粧料には、前述成分の他に1通常化粧料に用
いられる添加成分、例えば、界面活性剤、油脂類、アル
コール類、保湿剤、増粘剤、防腐剤。In addition to the above-mentioned components, the cosmetic of the present invention may contain additive components commonly used in cosmetics, such as surfactants, oils and fats, alcohols, humectants, thickeners, and preservatives.
酸化防止剤、キレート剤、pHtA9Qi剤、香料1色
素。Antioxidant, chelating agent, pHtA9Qi agent, fragrance 1 pigment.
紫外線吸収・散乱剤、水等を配合可能である。これらの
添加成分具体例を示すと、例えば、界面活性剤としては
、親油型グリセリンモノステアレート、自己乳化型グリ
セリンモノステアレート、ポリグリセリンモノステアレ
ート、ソルビタンモノオレート、ポリエチレングリコー
ルモノステアレート、ポリオキシエチレンソルビタンモ
ノオレート、ポリオキシエチレンセチルエーテル、ポリ
オキシエチレン化ステロール、ポリオキシエチレン化ラ
ノリン、ポリオキシエチレン化ミツロウ、ポリオキシエ
チレン硬化ヒマシ油等のノニオン界面活性剤;ステアリ
ン酸ナトリウム、パルミチン酸カリウム、セチル硫酸ナ
トリウム、ラウリルリン酸ナトリウム、パルミチン酸ト
リエタノールアミン、ポリオキシエチレンラウリルリン
酸ナトリウム、N−アシルグルタミン酸ナトリウム等の
アニオン界面活性剤;塩化ステアリルジメチルベンジル
アンモニウム、塩化ステアリルトリメチルアンモニウム
等のカチオン界面活性剤;塩酸アルキルアミノエチルグ
リシン液、レシチン等の両性界面活性剤等を例示するこ
とができる。Ultraviolet absorbing/scattering agents, water, etc. can be added. Specific examples of these additive components include, for example, as surfactants, lipophilic glycerin monostearate, self-emulsifying glycerin monostearate, polyglycerin monostearate, sorbitan monooleate, polyethylene glycol monostearate, Nonionic surfactants such as polyoxyethylene sorbitan monooleate, polyoxyethylene cetyl ether, polyoxyethylene sterol, polyoxyethylene lanolin, polyoxyethylene beeswax, polyoxyethylene hydrogenated castor oil; sodium stearate, palmitic acid Anionic surfactants such as potassium, sodium cetyl sulfate, sodium lauryl phosphate, triethanolamine palmitate, sodium polyoxyethylene lauryl phosphate, and sodium N-acylglutamate; cationic surfactants such as stearyldimethylbenzylammonium chloride and stearyltrimethylammonium chloride. Surfactant: Examples include amphoteric surfactants such as alkylaminoethylglycine hydrochloride solution and lecithin.
油脂類としては、ヒマシ油、オリーブ油、カカオ脂、椿
油、ヤシ油、木ロウ、ホホバ油、グレープシード油、ア
ボガド油等の植物油脂類;ミンク油、卵黄油等の動物油
脂類:ミツロウ、鯨ロウ、ラノリン、カルナウバロウ、
キャンデリラロウ等のロウ類;流動パラフィン、スクワ
ラン、マイクロクリスタリンワックス、セレシンワック
ス、パラフィンワックス、ワセリン等の炭化水素類;ラ
ウリン酸、ミリスチン酸、ステアリン酸、オレイン酸、
イソステアリン酸、ベヘニン酸等の天然及び合成脂肪酸
類;セタノール、ステアリルアルコール、ヘキシルデカ
ノール、オクチルドデカノール、ラウリルアルコール等
の天然及び合成高級アルコール類;ミリスチン酸イソプ
ロピル、パルミチン酸イソプロピル、ミリスチン酸オク
チルドデシル、オレイン酸オクチルデドシル、コレステ
ロールオレート等のエステル類を例示することができる
。Examples of oils and fats include vegetable oils such as castor oil, olive oil, cacao butter, camellia oil, coconut oil, wood wax, jojoba oil, grapeseed oil, and avocado oil; animal oils and fats such as mink oil and egg yolk oil; beeswax, whale oil, etc. wax, lanolin, carnauba wax,
Waxes such as candelilla wax; hydrocarbons such as liquid paraffin, squalane, microcrystalline wax, ceresin wax, paraffin wax, petrolatum; lauric acid, myristic acid, stearic acid, oleic acid,
Natural and synthetic fatty acids such as isostearic acid and behenic acid; natural and synthetic higher alcohols such as cetanol, stearyl alcohol, hexyldecanol, octyldodecanol, lauryl alcohol; isopropyl myristate, isopropyl palmitate, octyldodecyl myristate, oleic acid Examples include esters such as octyl dedocyl and cholesterol oleate.
保湿剤としては、グリセリン、プロピ−レンゲリコール
、1.3−ブチレンゲリコール、ソルビトール、ポリエ
チレングリコール、ジプロピレングリコール等の多価ア
ルコール類;アミノ酸、乳酸ナトリウム、ピロリドンカ
ルボン酸ナトリウム等のNMF成分、ヒアルロン酸、コ
ラーゲン、ムコ多糖類。Moisturizing agents include polyhydric alcohols such as glycerin, propylene gellicol, 1,3-butylene gellicol, sorbitol, polyethylene glycol, and dipropylene glycol; amino acids, NMF components such as sodium lactate, sodium pyrrolidone carboxylate, and hyaluronic acid. Acid, collagen, mucopolysaccharides.
コンドロイチン硫酸等の水溶性高分子物質等を例示する
ことができる。Examples include water-soluble polymeric substances such as chondroitin sulfate.
増粘剤としては、アルギン酸ナトリウム、キサンタンガ
ム、硅酸アルミニウム、マルメロ種子抽出物、トラガン
トガム、デンプン等の天然高分子物質;メチルセルロー
ス、ヒト′ロキシエチルセルロース、カルボキシメチル
セルロース、可溶性デンプン、カチオン化セルロース等
の半合成高分子物質;カルボキシビニルポリマー、ポリ
ビニルアルコール等の合成高分子物質等を例示すること
ができる。Thickeners include natural polymeric substances such as sodium alginate, xanthan gum, aluminum silicate, quince seed extract, tragacanth gum, and starch; semisynthetic substances such as methylcellulose, human-oxyethylcellulose, carboxymethylcellulose, soluble starch, and cationized cellulose. Polymeric substances; synthetic polymeric substances such as carboxyvinyl polymers and polyvinyl alcohol can be exemplified.
防腐剤としては、安息香酸塩、サリチル酸塩、ソルビン
酸塩、デヒドロ酢酸塩、バラオキシ安息香酸エステル、
2,4.4’−トリクロロ−2′−ヒドロキシジフェニ
ルエーテル、3,4.4’−トリクロロカルバニリド、
塩化ベンザルコニウム、ヒノキチオール、レゾルシン、
エタノール等を例示するlことができる。Preservatives include benzoate, salicylate, sorbate, dehydroacetate, hydroxybenzoic acid ester,
2,4,4'-trichloro-2'-hydroxydiphenyl ether, 3,4,4'-trichlorocarbanilide,
Benzalkonium chloride, hinokitiol, resorcinol,
Examples include ethanol and the like.
酸化防止剤としては、ジブチルヒドロキシトルエン、ブ
チルヒドロキシアニソール、没食子酸プロピル、アスコ
ルビン酸等を例示することができる。さらに、キレート
剤としては、エデト酸二ナトリウム、エチレンジアミン
四酢酸塩、ピロリン酸塩、ヘキサメタリン酸塩、クエン
酸、酒石酸、グルコン酸等を、pH調整剤としては、水
酸化ナトリウム、トリエタノールアミン、クエン酸、ク
エン酸ナトリウム、ホウ酸、ホウ砂、リン酸水素カリウ
ム等をそれぞれ例示することができる。Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole, propyl gallate, ascorbic acid, and the like. Furthermore, chelating agents include edetate disodium, ethylenediaminetetraacetate, pyrophosphate, hexametaphosphate, citric acid, tartaric acid, gluconic acid, etc., and pH adjusting agents include sodium hydroxide, triethanolamine, citric acid, etc. Examples include acids, sodium citrate, boric acid, borax, potassium hydrogen phosphate, and the like.
紫外線吸収・散乱剤については、2−ヒドロキシ−4−
メトキシベンゾフェノン、オクチルジメチルパラアミノ
ベンゾエート、エチルへキシルパラメトキシサイナメー
ト、Wn化チタン、カオリン、タルク等を例示すること
ができる。尚、任意成分は、これらに限定されるもので
はない。上記必須成分と任意成分を適当に配合すること
により、クリーム、乳液、化粧水、パック剤、パウダー
、リップクリーム、口紅、アンダーメークアップ、ファ
ンデーション、サンケア等種々の製品形態として用いる
ことが可能である。For ultraviolet absorbing and scattering agents, 2-hydroxy-4-
Examples include methoxybenzophenone, octyl dimethyl para-aminobenzoate, ethylhexyl para-methoxycynamate, titanium oxide, kaolin, and talc. Note that the optional components are not limited to these. By appropriately blending the above essential ingredients and optional ingredients, it can be used in various product forms such as creams, milky lotions, lotions, packs, powders, lip balms, lipsticks, under makeup, foundations, sun care, etc. .
本発明の化粧料の具体例について示すと1例えば、皮膚
用クリームとしては;必須成分:0.02〜10%。A specific example of the cosmetic of the present invention will be shown below. For example, as a skin cream: Essential ingredients: 0.02 to 10%.
油分:20〜70%、界面活性剤:2〜7%、保湿剤:
5〜■部。Oil content: 20-70%, surfactant: 2-7%, humectant:
5~■ part.
精製水:バランス、防腐剤:微量、香料:微量を含有す
る組成物、乳液としては;必須成分:0.02〜10%
。Purified water: balance, preservative: trace amount, fragrance: composition containing trace amount; as emulsion; essential ingredients: 0.02-10%
.
油分:10〜40%、界面活性剤:l−5%、保湿剤:
5〜10%。Oil content: 10-40%, surfactant: l-5%, humectant:
5-10%.
精製水:バランス、防腐剤:微量、香料:微量を含有す
る組成物、化粧水としては;必須成分:0.02〜10
%、アルコール類: 2−50%、界面活性剤=0.5
〜2で。Purified water: balance, preservative: trace amount, fragrance: composition containing trace amount, as a lotion; essential ingredients: 0.02-10
%, alcohol: 2-50%, surfactant = 0.5
In ~2.
保湿剤:2〜8%、酸化防止剤:0.01〜0.05%
、キレート剤:0.02〜0.1%、 pu調整剤:0
.05〜0.2%、精製水:バランス、防腐剤:微量、
色素:微量、香料:微量を含有する組成物、パック剤と
しては;必須成分:0.02−10%、7/L/l −
/L/類: 2−30%、保湿剤:2−10%。Moisturizer: 2-8%, antioxidant: 0.01-0.05%
, chelating agent: 0.02-0.1%, PU regulator: 0
.. 05-0.2%, purified water: balance, preservative: trace amount,
A composition containing a trace amount of pigment, a trace amount of fragrance, as a pack; Essential ingredients: 0.02-10%, 7/L/l -
/L/ type: 2-30%, moisturizer: 2-10%.
無機粉体:0〜20%、造膜剤=10〜20%、防腐剤
:微量、香料:微量を含有する組成物等が挙げられる。Examples include compositions containing inorganic powder: 0 to 20%, film-forming agent: 10 to 20%, preservative: trace amount, fragrance: trace amount.
本発明によれば、従来品よりも美白効果にすぐれ、しか
も安全性の高い化粧料が提供される。According to the present invention, a cosmetic is provided which has a superior whitening effect and is highly safe than conventional products.
従って、本発明の化粧料は、各種化粧用クリーム、乳液
、化粧水、パック剤、パウダー、リップクリーム、口紅
、アンダーメークアップ、ファンデーション、サンケア
等種々の製品形態で、特に皮膚化粧料として好適に使用
できる6
次に、本発明を実施例によりさらに詳細に説明する。Therefore, the cosmetics of the present invention can be used in various product forms such as various cosmetic creams, emulsions, lotions, packs, powders, lip balms, lipsticks, under makeup, foundations, sun care, etc., and are especially suitable as skin cosmetics. 6 Next, the present invention will be explained in more detail with reference to Examples.
実施例1
本発明の化粧料による美白効果を証明するため、C57
ブラツクマウスの背部を用いて、UVB(紫外線)照射
により増加する活性メラノサイトの抑制効果を調べた。Example 1 In order to prove the whitening effect of the cosmetic of the present invention, C57
Using the backs of black mice, the inhibitory effect on active melanocytes increased by UVB (ultraviolet) irradiation was investigated.
試験方法は下記の通りである。The test method is as follows.
(1)検体
検体の成分組成(重量%)は表−1に示した通りである
。(1) Sample The component composition (weight %) of the sample is as shown in Table-1.
(2)活性メラノサイト抑制効果試験
C57ブラツクマウス(各群3匹)の背部を毛刈りし、
ワックスで脱毛した後、1/2MEDth1のUVB
(紫外線)を1日1回、1週間照射する。検体の塗布は
、照射前又は照射後に1日1回行った。また、評価時期
は試験終了後3日目に行ない、検体の未塗布の活性メラ
ノサイト数を基準に抑制率を算出した。尚、活性メラノ
サイト数の測定は、2N臭化ナトリウム処理で表皮剥離
し、ドーパ染色後、顕微鏡で数えた6その結果を表−1
に示す。(2) Active melanocyte suppression effect test The backs of C57 black mice (3 mice in each group) were shaved,
After hair removal with wax, 1/2 MEDth1 UVB
(Ultraviolet light) is irradiated once a day for one week. The specimen was applied once a day before or after irradiation. Furthermore, the evaluation was performed on the third day after the end of the test, and the inhibition rate was calculated based on the number of active melanocytes in the specimen that had not been coated. The number of active melanocytes was measured by exfoliating the epidermis with 2N sodium bromide treatment, staining with Dopa, and counting using a microscope6.The results are shown in Table 1.
Shown below.
表−1の結果から、コウジ酸成分とフィトステロール及
び両者を含有する本発明のものは、コウジ酸成分単独の
ものより明らかに活性メラノサイトの抑制効果が改善さ
れていることがわかる。また、フィトステロール成分を
併用した効果は、紫外線照射前に塗布した方が照射後に
比べ、より効果が顕著である。From the results in Table 1, it can be seen that the products of the present invention containing a kojic acid component and a phytosterol, as well as both, have a clearly improved inhibitory effect on active melanocytes compared to a product containing only a kojic acid component. Furthermore, the effect of using a phytosterol component in combination is more pronounced when applied before ultraviolet irradiation than after irradiation.
実施例2
更に1本発明化粧料の美白効果を証明するため、有色モ
ルモットの背部を用いて脱色効果を調べた。Example 2 Furthermore, in order to prove the whitening effect of the cosmetic composition of the present invention, the bleaching effect was investigated using the backs of colored guinea pigs.
試験方法は下記の通りである。The test method is as follows.
(1)検体
表−2に示した美白成分を含み、エタノール 〜%及び
残部が精製水からなる化粧水を調製した。(1) A lotion containing the whitening ingredients shown in Sample Table 2 and consisting of ~% ethanol and the balance purified water was prepared.
(2)脱色効果試験
有色モルモット(各群3匹)の背部を毛刈りした後、各
化粧水50μQ’1r−1日1回、週5回の割で約4d
の範囲に3週間塗布し、試験終了4日目の皮膚色を色差
計で計測した。その結果を表−2に示す。(2) Depigmentation effect test After shaving the backs of colored guinea pigs (3 animals in each group), 50 μQ'1r of each lotion - once a day, 5 times a week, approximately 4 d
The skin color was measured using a color difference meter on the 4th day after the test was completed. The results are shown in Table-2.
表−2の結果から、コウジ酸成分とフィトステロール成
分の両者を含有する本発明の化粧水は、コウジ酸成分単
独の化粧水より脱色効果が優れていることがbかる。From the results in Table 2, it can be seen that the lotion of the present invention containing both a kojic acid component and a phytosterol component has a better decolorizing effect than a lotion containing only a kojic acid component.
実施例3 本発明の係る各種化粧料例を次に示す。Example 3 Examples of various cosmetics according to the present invention are shown below.
〈クリーム〉
A:油相部
流動パラフィン(#70) 5.0重景
%スクワラン 15.0 #セト
ステアリルアルコール 5.O〃密ロウ
2.0〃モノステアリン酸グリセリン
2.0〃POE(20)ソルビタンモノラウレー
ト2.011プロピルパラベン Q、l
nフィトステロール 1.Q n
B:水相部
コウジ酸 0.5重量2ヒアル
ロン酸 0.2〃メチルパラベン
0.2〃精製水
バランス
C:香料 適量
上方物A、 Bを70℃でそれぞれ混合溶解した後、B
にAを加え均一に乳化する。更にCを加えて冷却し、ク
リームを調製する。<Cream> A: Oil phase liquid paraffin (#70) 5.0 heavy weight% squalane 15.0 #cetostearyl alcohol 5. O〃Secret wax
2.0 Glyceryl monostearate 2.0 POE (20) Sorbitan monolaurate 2.011 Propyl paraben Q, l
n-phytosterol 1. Q n
B: Aqueous phase Kojic acid 0.5 weight 2 Hyaluronic acid 0.2 Methyl paraben
0.2〃Purified water
Balance C: Fragrance After mixing and dissolving appropriate amounts of ingredients A and B at 70℃, add B.
Add A to the mixture and emulsify it uniformly. Further, add C and cool to prepare cream.
く乳 液〉
A:油相部
流動パラ7 イン(#70) 10.0重
ff%イソプロピルミリステート 2.0重量%
グリセリンモノステアレート 0.5〃ステアリン
酸 2.0〃POE(20)ステア
リルエーテル 0.7〃POE(5)フィトステロ
ール 2.O〃グリチルレチン酸
0.1〃ブチルパラベン 0.1
〃B:水相部
コウジ@ O,S重景Iト
リエタノールアミン 0.5〃グリセリン
2.0〃力一ボボール941
Q、l nエタノール
10.0 IIメチルパラベン
Q、l n精製水 バラ
ンスC:香料 適量
上記処方物A、 Bを70℃でそれぞれ混合溶解し。Emulsion liquid〉 A: Oil phase liquid Para 7 in (#70) 10.0 wt ff% isopropyl myristate 2.0 wt%
Glycerin monostearate 0.5 Stearic acid 2.0 POE (20) Stearyl ether 0.7 POE (5) Phytosterol 2. O Glycyrrhetinic acid
0.1 Butylparaben 0.1
〃B: Water phase part Koji @ O, S heavy picture I triethanolamine 0.5〃Glycerin
2.0 Rikiichi Bobball 941
Q, l nethanol
10.0 II Methylparaben
Q, ln Purified water Balance C: Fragrance Mix and dissolve appropriate amounts of the above formulations A and B at 70°C.
Aを加え均一に乳化する。更にCを加えて冷却し、乳液
を調製する。Add A and emulsify uniformly. Further, add C and cool to prepare a milky lotion.
〈化粧水〉
A:エチルアルコール相部
エチルアルコール 10.0重量2PO
E(80)硬化ヒマシ油 0.3〃フイトス
テロールパルミテート 0.l〃トコフェロール
0.1〃メチルパラベン
0.1重量%香料 適量
B:水相部
コウジ酸 0.1重+A%グリ
セリン 3.0〃精製水
バランス上記処方物Aを均一に溶解後、こ
れをBの水相部に撹拌しながら徐々に加え、化粧水を調
製する。<Lotion> A: Ethyl alcohol phase Ethyl alcohol 10.0 weight 2PO
E (80) Hydrogenated castor oil 0.3 Phytosterol palmitate 0. l〃Tocopherol
0.1〃Methylparaben
0.1% by weight fragrance Appropriate amount B: Water phase Kojic acid 0.1% weight + A% glycerin 3.0〃Purified water
Balance After uniformly dissolving the above formulation A, it is gradually added to the aqueous phase of B while stirring to prepare a lotion.
〈パック剤〉
A:エチルアルコール相部
エチルアルコール 1000重量2ポリ
ビニルアルコール 15.OITプロピレン
グリコール 3.0〃メチルパラベン
Q、l nブチルパラベン
o、os upoc(5)フィトステロール
2.5 I+グリチルリチン酸
0.l〃B:水相部
コウジ酸ナトリウム 1.0重量%カルボ
キシメチルセルロースナトリウム5.0I
POR(15)オレイルエーテル 1.O〃精製
水 バランス
C:香 料 適 量
上記処方物AとBを混合し、70℃で均一に加温混合し
た。更に冷却しながら処方物Cを加えて、パック剤を特
徴する<Pack agent> A: Ethyl alcohol phase Ethyl alcohol 1000 weight 2 Polyvinyl alcohol 15. OIT Propylene Glycol 3.0 Methylparaben
Q, l n-butylparaben
o, os upoc (5) phytosterol
2.5 I+glycyrrhizic acid
0. l〃B: Aqueous phase Sodium kojate 1.0% by weight Sodium carboxymethylcellulose 5.0I POR (15) Oleyl ether 1. O〃Purified water Balance C: Fragrance Appropriate amount The above formulations A and B were mixed and heated and mixed uniformly at 70°C. While further cooling, add Formulation C to characterize the pack.
Claims (3)
I )で表わされるフィトステロール及び/又はその誘導
体を含有することを特徴とする美白化粧料。 一般式( I ) ▲数式、化学式、表等があります▼ (式中R_1は水素原子、炭素数3〜22のアルキル基
、炭素数3〜22のアルコキシ基、ポリオキシ化アルキ
レン(炭素数2〜3)残基又は糖残基を表わし、R_2
はデシル基、デセニル基又はノニル基を表わす)(1) Kojic acid and/or its derivatives and the following general formula (
A whitening cosmetic containing a phytosterol represented by I) and/or a derivative thereof. General formula (I) ▲ Numerical formulas, chemical formulas, tables, etc. ) residue or sugar residue, R_2
represents a decyl group, decenyl group or nonyl group)
ール及び/又はその誘導体が、β−シトステロール、ス
チグマステロール、カンペステロールおよびそれら化合
物の脂肪酸エステル、脂肪族エーテル、ポリオキシアル
キレン化合物もしくは配糖体の中から選ばれた1種また
は2種以上からなる特許請求の範囲第(1)項記載の美
白化粧料。(2) The phytosterol represented by the above general formula (I) and/or its derivatives are β-sitosterol, stigmasterol, campesterol and fatty acid esters, aliphatic ethers, polyoxyalkylene compounds or glycosides of these compounds. The whitening cosmetic according to claim (1), comprising one or more selected from the following.
の配合量が0.01〜10重量%であり、且つ、上記の
一般式( I )で表わされるフィトステロール及び/又
はその誘導体の1種または2種以上の配合量が0.01
〜25重量%である特許請求の範囲第(1)項記載の美
白化粧料。(3) The whitening cosmetic contains 0.01 to 10% by weight of kojic acid and/or a derivative thereof, and one of the phytosterols and/or derivatives thereof represented by the above general formula (I). The content of the species or two or more species is 0.01
The whitening cosmetic according to claim (1), wherein the content is 25% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25187587A JPH0196109A (en) | 1987-10-06 | 1987-10-06 | Skin-beautifying cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25187587A JPH0196109A (en) | 1987-10-06 | 1987-10-06 | Skin-beautifying cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0196109A true JPH0196109A (en) | 1989-04-14 |
Family
ID=17229233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP25187587A Pending JPH0196109A (en) | 1987-10-06 | 1987-10-06 | Skin-beautifying cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0196109A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01275515A (en) * | 1988-04-27 | 1989-11-06 | Sansho Seiyaku Co Ltd | Make-up cosmetic |
WO2000069404A1 (en) * | 1999-05-17 | 2000-11-23 | The Procter & Gamble Company | Methods for regulating the condition of mammalian keratinous tissue via topical application of phytosterol compositions |
KR100309398B1 (en) * | 1993-10-28 | 2002-02-19 | 진나이 스네요 | External skin preparation |
KR100309400B1 (en) * | 1993-10-28 | 2002-02-28 | 진나이 스네요 | External skin preparation |
KR20030061985A (en) * | 2002-01-14 | 2003-07-23 | (주)대덕바이오 | Melanin synthesis inhibition compound and its composition containing stigmasterol |
JP2012148988A (en) * | 2011-01-18 | 2012-08-09 | Nippon Menaade Keshohin Kk | External preparation or internal preparation |
US20140328928A1 (en) * | 2002-01-03 | 2014-11-06 | Christopher J. Milley | Stable Aqueous Suspension |
JP2016060734A (en) * | 2014-09-22 | 2016-04-25 | 株式会社ファンケル | Arginase 1 production promoter |
-
1987
- 1987-10-06 JP JP25187587A patent/JPH0196109A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01275515A (en) * | 1988-04-27 | 1989-11-06 | Sansho Seiyaku Co Ltd | Make-up cosmetic |
KR100309398B1 (en) * | 1993-10-28 | 2002-02-19 | 진나이 스네요 | External skin preparation |
KR100309400B1 (en) * | 1993-10-28 | 2002-02-28 | 진나이 스네요 | External skin preparation |
WO2000069404A1 (en) * | 1999-05-17 | 2000-11-23 | The Procter & Gamble Company | Methods for regulating the condition of mammalian keratinous tissue via topical application of phytosterol compositions |
US20140328928A1 (en) * | 2002-01-03 | 2014-11-06 | Christopher J. Milley | Stable Aqueous Suspension |
US9775910B2 (en) * | 2002-01-03 | 2017-10-03 | Ingredient Innovations International | Stable aqueous suspension |
KR20030061985A (en) * | 2002-01-14 | 2003-07-23 | (주)대덕바이오 | Melanin synthesis inhibition compound and its composition containing stigmasterol |
JP2012148988A (en) * | 2011-01-18 | 2012-08-09 | Nippon Menaade Keshohin Kk | External preparation or internal preparation |
JP2016060734A (en) * | 2014-09-22 | 2016-04-25 | 株式会社ファンケル | Arginase 1 production promoter |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2886591B2 (en) | Cosmetics | |
JP2003095915A (en) | Skin care composition | |
KR102359729B1 (en) | Cosmetic Composition for Reducing Stickiness and Improving Transparency of Emulsion Formulation | |
JPH11193207A (en) | Preparation for external use for skin | |
JPH0657651B2 (en) | Cosmetic composition | |
CA2365660A1 (en) | Treatment for skin | |
JP2000016917A (en) | Skin whitening cosmetic | |
JPH0196109A (en) | Skin-beautifying cosmetic | |
JP2001233754A (en) | Emulsion type skin care preparation | |
JPH11139951A (en) | Cosmetic | |
JPH11199426A (en) | Cosmetic | |
JPH01121205A (en) | Skin beautifying cosmetic | |
JPH11292752A (en) | Beautifully whitening agent and composition for external use for skin | |
JP2000212057A (en) | Cosmetic composition | |
JP2786233B2 (en) | External preparation for skin | |
JPH01121206A (en) | Skin beautifying cosmetic | |
JPH1160462A (en) | Skin cosmetic | |
JPS6023307A (en) | Skin beautifying cosmetic | |
JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
JP3349544B2 (en) | Skin cosmetics | |
JP2000256168A (en) | Skin lotion | |
JPH041115A (en) | Dermal drug for external use | |
JPH01121207A (en) | Skin beautifying cosmetic | |
JP2000229811A (en) | Skin lotion | |
JP2002284666A (en) | Cosmetics |